Informazioni sul fornitore
Certificazioni
-
ISO 13485
Descrizione del prodotto
Bioabsorbable Evolvemer™ TCP30PLGA is a biocompatible composite of bioabsorbable 85L/15G PLGA base polymer and beta-tri-calcium phosphate (β-TCP).
The β-TCP particle size distribution is optimized in this high-quality composite. This makes its processing easier and improves the mechanical properties of the final products.
Biocompatibility of the Evolvemer™ Composite has been evaluated according to ISO 10993-1:2009 (“Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”). Based on the evaluation, Evolvemer™ Composite presents no risk of systemic toxicological effects.
Cytotoxicity and Plastic Class V tests have been conducted for Evolvemer™ Composite to support the biocompatibility statement of the composite. However, it is the sole responsibility of the manufacturer of the final end-use product to determine the biocompatibility of the final product.
Specifiche tecniche
| Marchio | arctic biomaterials, evolvemer™ |
| Applicazioni | orthopedics, sports medicine, veterinary, dental |
| Materiale | plga + β-tcp |
| Designazione chimica | - non specificato - |
| Densità | - non specificato - |
| Porosità | - non specificato - |
| Lavorabilità | - non specificato - |
| Biodegradabilità | - non specificato - |
| Riassorbibilità | - non specificato - |
| Rinforzo (Composito) | - non specificato - |
Prodotti simili
Arctic Biomaterials (ABM) specializes in ultra-high strength, bioresorbable materials featuring its...
Evolvecomp™ next-generation bioabsorbable composites are engineered with ABM’s X3 bioactive natural...